OR.PA : Summary for L''OREAL - Yahoo Finance

U.S. Markets open in 8 hrs 29 mins

L'Oréal S.A. (OR.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
170.50+0.95 (+0.56%)
At close: 5:35PM CET
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close169.55
Bid167.00 x 6000
Ask169.85 x 35000
Day's Range168.90 - 170.70
52 Week Range146.20 - 177.90
Avg. Volume559,224
Market Cap95.46B
PE Ratio (TTM)33.29
Earnings DateN/A
Dividend & Yield3.57 (1.96%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters20 hours ago

    GSK grabs Astra executive to replace pharma head

    LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.

  • Reuters9 days ago

    Valeant to sell assets for $2.12 billion to ease debt load

    Valeant's U.S.-listed shares (VRX.N) rose as much as 14 percent on Tuesday, before paring gains to 5.7 percent at $16.22 in afternoon trading. Laval, Quebec-based Valeant has been the subject of recent investigations by congressional panels as well as the Federal Trade Commission and the U.S. Securities and Exchange Commission. French cosmetics group L'Oreal (OREP.PA) is buying CeraVe, AcneFree and Ambi from Valeant for about $1.3 billion in cash.

  • Benzinga10 days ago

    Valeant's Asset Sale To L'Oreal Explained

    Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) announced an agreement to sell its CeraVe, AcneFree and AMBI Skincare brands to L'Oreal SA (ADR) (OTC: LRLCY ) for $1.3 billion. According to Gadfly's Andrea ...